C12N 2760/20122
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2760/20122 (New viral proteins or individual genes, new structural or functional aspects of) appears on 119 US grants and 110 published applications in this corpus.
Search patents in C12N- Granted patents
- 119
- Published applications
- 110
- Assignees
- 72
- Inventors
- 262
- Latest grant
- 15 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 2 | 0 |
| 1996 | 3 | 0 |
| 1997 | 3 | 0 |
| 1998 | 12 | 0 |
| 1999 | 5 | 0 |
| 2000 | 4 | 0 |
| 2001 | 5 | 1 |
| 2002 | 3 | 4 |
| 2003 | 4 | 7 |
| 2004 | 5 | 5 |
| 2005 | 1 | 5 |
| 2006 | 2 | 4 |
| 2007 | 5 | 4 |
| 2008 | 1 | 9 |
| 2009 | 3 | 2 |
| 2010 | 7 | 6 |
| 2011 | 1 | 3 |
| 2012 | 6 | 6 |
| 2013 | 3 | 4 |
| 2014 | 3 | 3 |
| 2015 | 6 | 5 |
| 2016 | 4 | 1 |
| 2017 | 3 | 4 |
| 2018 | 2 | 1 |
| 2019 | 0 | 2 |
| 2020 | 4 | 1 |
| 2021 | 0 | 5 |
| 2022 | 4 | 3 |
| 2023 | 3 | 11 |
| 2024 | 2 | 9 |
| 2025 | 1 | 2 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Vaccine composition for preventing rabies, and preparation method thereof15 Jul 2025US 12,357,685 B2Bioapplications Inc.
- Coronavirus disease (COVID-19) vaccine7 May 2024US 11,975,067 B2Thomas Jefferson University
- Particle delivery systems7 May 2024US 11,976,277 B2Scribe Therapeutics Inc.
- Optically controlled virus protein, gene thereof, and virus vector containing said gene12 Sep 2023US 11,753,448 B2The University of Tokyo
- Compositions and methods for the prevention and treatment of rabies virus infection22 Aug 2023US 11,730,804 B1Replicate Bioscience, Inc.
- Expression construct10 Sep 2026US 2026/0265777 A1Lentitek Ltd
- Arrdc1-mediated microvesicle-based delivery of therapeutic agents to cells of the peripheral nervous system27 Aug 2026US 2026/0248957 A1Turn Biotechnologies, Inc.
- Sarna delivery system, preparation method therefor and use thereof23 Apr 2026US 2026/0110000 A1Zhejiang Free Trade Zone Hongan Base Biotechnology Co., Ltd.
- Compositions and methods for the prevention and treatment of rabies virus infection12 Jun 2025US 2025/0186574 A1Replicate Bioscience, Inc.
- Rabies g protein and uses thereof5 Jun 2025US 2025/0177513 A1Icosavax, Inc.
Most cited
By later US patents
- Recombinant infectious non-segmented negative strand RNA virus156US 6,033,886 A2000
- Recombinant avipox virus and immunological use thereof151US 5,174,993 AHealth Research, Inc. · 1992
- NYVAC vaccinia virus recombinants comprising heterologous inserts137US 5,494,807 AVirogenetics Corporation · 1996
- Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence128US 5,833,975 AVirogenetics Corporation · 1998
- Recombinant poxvirus host range selection system127US 5,225,336 AHealth Research, Inc. · 1993